FAP and non-small cell lung carcinoma: Thanks to the sc-RNA studies FAP+ CAFs have been deeply phenotyping, and different groups have observed highly heterogeneity of this subpopulation in NSCLC (30, 46–49), bladder (50), pancreas (51, 52), BC (53), liver (54) and HN (55) tumors.